在急性髓性白血病中,STAT5促进PD-L1表达,通过促进基因素乳化来驱动免疫抑制,从而促进PD-L1表达
Ze-Wei Huang1, Xue-Ning Zhang1, Ling Zhang1
1Department of Hematology, The Third Affiliated Hospital, Sun Yat-sen University; Institute of Hematology, Sun Yat-sen University, Guangzhou, China.
Signal transduction and targeted therapy
|September 30, 2023
概括
在急性髓性白血病 (AML) 细胞中,STAT5激活促进糖解和乳酸盐的产生,导致PD-L1的表达. 这种STAT5-乳酸盐-PD-L1网络表明,高STAT5的AML患者可能受益于PD-1/PD-L1免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),在各种癌症中表现有前途,包括血液恶性瘤.
- 急性髓性白血病 (AML) 是一种复杂的疾病,PD-1/PD-L1阻断性免疫治疗的成功程度有限.
- 在AML中确定免疫疗法分层的新目标至关重要.
研究的目的:
- 阐明驱动AML免疫抑制的分子机制.
- 确定用于预测AML患者对PD-1/PD-L1抑制剂的反应的生物标志物.
- 研究STAT5在AML进展和免疫逃避中的作用.
主要方法:
- 在AML患者队列中分析STAT5表达.
- 调查STAT5对糖溶性基因促进体的影响.
- 测量乳酸积累和基因素乳酸化.
- 评估PD-L1转录及其调节.
- 评估ICI在共同培养模型中的有效性.
- 将临床数据与分子发现相关联.
主要成果:
- 在AML中STAT5的表达很高,并促进糖解,增加乳酸水平.
- 乳酸盐的积累促进了组织素的乳糖化,并增强了PD-L1转录.
- 在STAT5激活的AML模型中,PD-1/PD-L1阻塞可以破坏T细胞相互作用.
- 临床数据显示,AML患者的骨髓乳酸,STAT5和PD-L1表达之间存在正相关性.
结论:
- 在AML进展中发现了一种新的STAT5-乳酸盐-PD-L1轴.
- STAT5驱动的糖解和乳酸积累有助于AML的免疫逃避.
- 高STAT5和相关代谢变化的AML患者可能受益于PD-1/PD-L1基础的免疫疗法.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


